SIGA Technologies, Inc. (SIGA)
NASDAQ: SIGA · Real-Time Price · USD
5.94
+0.28 (4.95%)
At close: May 12, 2025, 4:00 PM
5.95
+0.01 (0.17%)
After-hours: May 12, 2025, 7:12 PM EDT
SIGA Technologies Market Cap
SIGA Technologies has a market cap or net worth of $424.36 million as of May 12, 2025. Its market cap has decreased by -31.08% in one year.
Market Cap
424.36M
Enterprise Value
263.31M
1-Year Change
-31.08%
Ranking
Category
Stock Price
$5.94
Market Cap Chart
Since December 1, 1998, SIGA Technologies's market cap has increased from $199.10M to $424.36M, an increase of 113.14%. That is a compound annual growth rate of 2.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 404.40M | -5.76% |
Dec 31, 2024 | 429.10M | 7.79% |
Dec 29, 2023 | 398.10M | -25.93% |
Dec 30, 2022 | 537.50M | -3.57% |
Dec 31, 2021 | 557.40M | -0.94% |
Dec 31, 2020 | 562.70M | 45.51% |
Dec 31, 2019 | 386.70M | -39.06% |
Dec 31, 2018 | 634.60M | 65.82% |
Dec 29, 2017 | 382.70M | 144.85% |
Dec 30, 2016 | 156.30M | 588.55% |
Dec 31, 2015 | 22.70M | -70.52% |
Dec 31, 2014 | 77.00M | -55.57% |
Dec 31, 2013 | 173.30M | 28.09% |
Dec 31, 2012 | 135.30M | 4.40% |
Dec 30, 2011 | 129.60M | -80.68% |
Dec 31, 2010 | 670.80M | 201.75% |
Dec 31, 2009 | 222.30M | 92.30% |
Dec 31, 2008 | 115.60M | 10.73% |
Dec 31, 2007 | 104.40M | -12.34% |
Dec 29, 2006 | 119.10M | 372.62% |
Dec 30, 2005 | 25.20M | -38.08% |
Dec 31, 2004 | 40.70M | -4.91% |
Dec 31, 2003 | 42.80M | -81.27% |
Dec 29, 2000 | 228.50M | 94.14% |
Dec 31, 1999 | 117.70M | 13.06% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |